{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:11:09Z","timestamp":1794316269041,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In this study, an ion pair RP-HPLC method has been developed for separation and quantification of imeglimin hydrochloride (IMG) in the existence of its processing impurity, metformin hydrochloride (MTF). The chromatographic analysis was performed using an XTerra\n                    <jats:sup>\u00ae<\/jats:sup>\n                    RP8 column (5\u00a0\u03bcm, 150\u2009\u00d7\u20094.6\u00a0mm) with a mobile phase consisting of a filtered and degassed mixture of 0.1% 1-octane sulfonic acid sodium salt and absolute ethanol (80:20,\n                    <jats:italic>%v\/v<\/jats:italic>\n                    ) at a constant flow rate of 1 mL\/min. Detection was performed at 241\u00a0nm using a photo diode array (PDA) detector. The method parameters were thoroughly evaluated and validated in accordance with ICH Q2 (R2) guidelines. Linearity was established over the range of 0.4\u201396.0\u00a0\u00b5g. mL\n                    <jats:sup>\u2212\u20091<\/jats:sup>\n                    . The use of ion pairing with octane sulfonic acid and ethanol as the mobile phase was effective in achieving an acceptable retention time for the determination of IMG in the presence of metformin and IMG degradation products. Peak purity analysis using PDA detector confirmed that degradation products did not interfere with IMG detection. Furthermore, the method was successfully applied for the accurate quantification of IMG in tablet dosage form, with no interference from excipients, confirming its specificity. Additionally, it was effectively utilized for in vitro dissolution testing of IMG in tablet form, following FDA guidelines. The greenness and applicability of the developed method were assessed using various tools such as the Analytical Eco-Scale, AGREE, MOGAPI, CAFRI, CACI and BAGI demonstrating its environment friendly nature and practicality.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-32999-4","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T17:23:45Z","timestamp":1768065825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Stability indicating green HPLC method for Imeglimin hydrochloride determination in pharmaceutical tablets with comprehensive assessment"],"prefix":"10.1038","volume":"16","author":[{"given":"Fotouh R.","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar H.","family":"Elagamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almoataz Bellah B.","family":"Elbastawissy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah F.","family":"EL-Malla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"32999_CR1","doi-asserted-by":"crossref","unstructured":"Uto, N. Asuka and Ishinoda, Yuki and Asaga, Takamasa and Tanahashi, Yuki and Kobayashi, Ai and Meshino, Hitomi and Okazaki, Maki and Tomita, Kengo and Kasuga, Akira and Oshima, Imeglimin for type 2 diabetes mellitus: its efficacy and insight into the potential benefit for renal and liver function. Cureus 16 (2024).","DOI":"10.7759\/cureus.66322"},{"key":"32999_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s40268-015-0099-3","volume":"15","author":"V Vuylsteke","year":"2015","unstructured":"Vuylsteke, V., Chastain, L. M., Maggu, G. A. & Brown, C. Imeglimin: A potential new Multi-Target drug for type 2 diabetes. Drugs R D. 15, 227\u2013232. https:\/\/doi.org\/10.1007\/s40268-015-0099-3 (2015).","journal-title":"Drugs R D"},{"key":"32999_CR3","doi-asserted-by":"publisher","first-page":"109785","DOI":"10.1016\/j.diabres.2022.109785","volume":"185","author":"H Wu","year":"2022","unstructured":"Wu, H. et al. Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021. Diabetes Res. Clin. Pract. 185, 109785 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"32999_CR4","doi-asserted-by":"publisher","unstructured":"Vial, S. H. G. et al. Mechanism of action of imeglimin: A novel therapeutic agent for type 2 diabetes, 664\u2013673 https:\/\/doi.org\/10.1111\/dom.14277. (2021).","DOI":"10.1111\/dom.14277"},{"key":"32999_CR5","first-page":"726","volume":"12","author":"H Yanai","year":"2023","unstructured":"Yanai, H., Adachi, H., Hakoshima, M. & Katsuyama, H. Glucose-lowering effects of Imeglimin and its possible beneficial effects on diabetic complications. Biology (Basel). 12, 726 (2023).","journal-title":"Biology (Basel)"},{"key":"32999_CR6","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s40265-021-01589-9","volume":"81","author":"YN Lamb","year":"2021","unstructured":"Lamb, Y. N. & Hydrochloride, I. First approval. Drugs 81, 1683\u20131690. https:\/\/doi.org\/10.1007\/s40265-021-01589-9 (2021).","journal-title":"Drugs"},{"key":"32999_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/CSJI\/2024\/v33i4901","volume":"33","author":"VS Adhao","year":"2024","unstructured":"Adhao, V. S., Chaudhari, S. P. & Ambhore, J. P. Stability indicating RP-HPLC method development and validation for Imeglimin HCL in pharmaceutical dosage form. Chem. Sci. Int. J. 33, 1\u201310 (2024).","journal-title":"Chem. Sci. Int. J."},{"key":"32999_CR8","doi-asserted-by":"publisher","unstructured":"Gogikar, S. K., Sen, S., Pathinti, S., Samanthula, G. & Dikundwar, A. G. Forced degradation study of an Anti-Diabetic drug imeglimin: impurity profiling and structure Elucidation using LC\u2010Q\u2010ToF\u2010MS\/MS and NMR. Rapid Commun. Mass. Spectrom. 39 https:\/\/doi.org\/10.1002\/rcm.9960 (2025).","DOI":"10.1002\/rcm.9960"},{"key":"32999_CR9","doi-asserted-by":"publisher","first-page":"852","DOI":"10.5281\/zenodo.10433883","volume":"1","author":"T Selvan","year":"2023","unstructured":"Selvan, T. A novel method development and validation of Imeglimin HCl by UV-Visible spectroscopy. Int. J. Pharm. Sci. 1, 852\u2013859. https:\/\/doi.org\/10.5281\/zenodo.10433883 (2023).","journal-title":"Int. J. Pharm. Sci."},{"key":"32999_CR10","first-page":"57","volume":"10","author":"YK Vachala","year":"2023","unstructured":"Vachala, Y. K., Manjunath, S. D., Pravat Ranjan, G. V., Shashi Prakash, B. & Srilakshmi, R. Development and validation of Imeglimin hydrochloride by UV\/ visible spectrophotometric method. Int. J. Res. Anal. Rev. 10, 57\u201367 (2023).","journal-title":"Int. J. Res. Anal. Rev."},{"key":"32999_CR11","doi-asserted-by":"publisher","first-page":"724","DOI":"10.25258\/ijddt.14.2.19","volume":"14","author":"S Jahagirdar","year":"2024","unstructured":"Jahagirdar, S., Godge, R., Vikhe, S. & Bornare, S. Estimation of Imeglimin in pharmaceutical tablets by RP-HPLC. Int. J. Drug Deliv Technol. 14, 724\u2013726. https:\/\/doi.org\/10.25258\/ijddt.14.2.19 (2024).","journal-title":"Int. J. Drug Deliv Technol."},{"key":"32999_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.22270\/ajprd.v12i4.1446","volume":"12","author":"G Mubeen","year":"2024","unstructured":"Mubeen, G., Navali, S. & Lalitha, N. Method for determination of Imeglimin hydrochloride in bulk and tablet formulation. Asian J. Pharm. Res. Dev. 12, 92\u201396 (2024).","journal-title":"Asian J. Pharm. Res. Dev."},{"key":"32999_CR13","unstructured":"Salvi, A. S., Khamkar, S. & Hingane, D. Development and validation of RP-HPLC method for estimation of anti-diabetic drug in bulk and tablet dosage form, J. Emerg. Technol. Innov. Res. 10 366\u2013378.A (2023)."},{"key":"32999_CR14","first-page":"211","volume":"15","author":"R Jain","year":"2023","unstructured":"Jain, R. & Sharma Development and validation of stability indicating RP-UHPLC method for the Estimation of Imeglimin hydrochloride used for the treatment of metabolic disorder diabetes mellitus. Int. J. Pharm. Sci. 15, 211\u2013217 (2023).","journal-title":"Int. J. Pharm. Sci."},{"key":"32999_CR15","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.31788\/RJC.2024.1749002","volume":"17","author":"AS Talati","year":"2024","unstructured":"Talati, A. S. & Dave, H. N. Forced degradation studies and assessment of degradation products of Imeglimin hydrochloride using LC-Esi\/Apci-Ms. Rasayan J. Chem. 17, 1903\u20131909. https:\/\/doi.org\/10.31788\/RJC.2024.1749002 (2024).","journal-title":"Rasayan J. Chem."},{"key":"32999_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trac.2013.04.010","volume":"50","author":"S Ga\u0142uszka","year":"2013","unstructured":"Ga\u0142uszka, S., Migaszewski, A. & Namie\u015bnik, Z. The 12 principles of green analytical chemistry and the SIGNIFICANCE mnemonic of green analytical practices. TrAC Trends Anal. Chem. 50, 78 (2013).","journal-title":"TrAC Trends Anal. Chem."},{"key":"32999_CR17","doi-asserted-by":"crossref","unstructured":"Hammad, S. F., Hamid, M. A. A., Adly, L. & Elagamy, S. H. Comprehensive review of Greenness, Whiteness, and blueness assessments of analytical methods. Green. Anal. Chem. 100209. (2025).","DOI":"10.1016\/j.greeac.2025.100209"},{"key":"32999_CR18","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.110035","author":"N Nakov","year":"2023","unstructured":"Nakov, N., Acevska, J., Brezovska, K., Kavrakovski, Z. & Dimitrovska, A. Green strategies toward Eco-Friendly HPLC methods in pharma Analysis, In: high Perform. Liq. Chromatogr. - Recent. Adv. Appl. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.110035 (2023).","journal-title":"- Recent. Adv. Appl. IntechOpen"},{"key":"32999_CR19","doi-asserted-by":"publisher","first-page":"113507","DOI":"10.1016\/j.jpba.2020.113507","volume":"190","author":"M Yabr\u00e9","year":"2020","unstructured":"Yabr\u00e9, M., Ferey, L., Som\u00e9, T. I., Sivadier, G. & Gaudin, K. Development of a green HPLC method for the analysis of Artesunate and amodiaquine impurities using quality by design. J. Pharm. Biomed. Anal. 190, 113507 (2020).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"32999_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1590\/S0103-50532004000200022","volume":"15","author":"RLV Ribeiro","year":"2004","unstructured":"Ribeiro, R. L. V., Bottoli, C. B. G., Collins, K. E. & Collins, C. H. Reevaluation of ethanol as organic modifier for use in HPLS-RP mobile phases. J. Braz Chem. Soc. 15, 300\u2013306 (2004).","journal-title":"J. Braz Chem. Soc."},{"key":"32999_CR21","first-page":"198","volume":"7","author":"AA Habib","year":"1981","unstructured":"Habib, A. A., Mabrouk, M. M., Hammad, S. F. & Megahed, S. M. Implementation of factorial design for optimization of forced degradation conditions and development of validated stability indicating RP-HPLC method for Lidocaine hydrochloride. Der Pharma Chem. 7, 198\u2013211 (1981).","journal-title":"Der Pharma Chem."},{"key":"32999_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jpha.2013.09.003","volume":"4","author":"M Blessy","year":"2014","unstructured":"Blessy, M., Patel, R. D., Prajapati, P. N. & Agrawal, Y. K. Development of forced degradation and stability indicating studies of drugs\u2014A review. J. Pharm. Anal. 4, 159\u2013165 (2014).","journal-title":"J. Pharm. Anal."},{"key":"32999_CR23","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1002\/jssc.202200322","volume":"45","author":"SH Elagamy","year":"2022","unstructured":"Elagamy, S. H., Mansour, F. R., Elbastawissy, A. B. B. & EL-Malla, S. F. Development of stability indicating reversed\u2010phase high\u2010performance liquid chromatography method for determination of Elobixibat in pure form and laboratory prepared tablets: application to dissolution study. J. Sep. Sci. 45, 3529\u20133541 (2022).","journal-title":"J. Sep. Sci."},{"key":"32999_CR24","first-page":"1","volume":"31","author":"H Brummer","year":"2011","unstructured":"Brummer, H. How to approach a forced degradation study. Life Sci. Technol. Bull. 31, 1\u20134 (2011).","journal-title":"Life Sci. Technol. Bull."},{"issue":"3","key":"32999_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/jssc.202001007","volume":"44","author":"AA Habib","year":"2021","unstructured":"Habib, A. A., Hammad, S. F., Amer, M. M. & Kamal, A. H. Stability indicating RP-HPLC method for determination of dimethyl fumarate in presence of its main degradation products: application to degradation kinetics. J. Sep. Sci. 44 (3), 726\u2013734 (2021).","journal-title":"J. Sep. Sci."},{"issue":"15","key":"32999_CR26","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1002\/jssc.202200132","volume":"45","author":"MM Amer","year":"2022","unstructured":"Amer, M. M., Kamal, A. H., Hammad, S. F. & Habib, A. A. Stability indicating RP-HPLC method for methylcobalamin determination in different dosage forms: application to photodegradation kinetics and pH rate profiling. J. Sep. Sci. 45 (15), 2877\u20132886 (2022).","journal-title":"J. Sep. Sci."},{"key":"32999_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13065-024-01177-4","volume":"18","author":"SH Elagamy","year":"2024","unstructured":"Elagamy, S. H. et al. Development of a stability indicating high-performance liquid chromatography method for determination of cenobamate: study of basic degradation kinetics. BMC Chem. 18, 74 (2024).","journal-title":"BMC Chem."},{"key":"32999_CR28","first-page":"1","volume":"4","author":"S Singh","year":"2000","unstructured":"Singh, S. & Bakshi, M. Stress test to determine inherent stability of drugs. Pharm. Technol. 4, 1\u201314 (2000).","journal-title":"Pharm. Technol."},{"key":"32999_CR29","unstructured":"Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral. Dosage form drug products containing high solubility drug substances guidance for industry, 8. https:\/\/www.fda.gov\/files\/drugs (2018)."},{"key":"32999_CR30","unstructured":"Guidance for Industry Dissolution Testing of Immediate Release Solid Oral Dosage Forms. 13. https:\/\/www.fda.gov\/media\/70936\/download (1997)."},{"key":"32999_CR31","unstructured":"United States Pharmacopeial Convention, The United States Pharmacopeia USP 48. National Formulary 43, 43rd ed. USA: United States Pharmacopeial Convention(USP), (2025)."},{"key":"32999_CR32","unstructured":"Kadams, N. T., Jadhavh, B. P. & Minhas, S. S. Process for preparation of imeglimin and salts, https:\/\/patents.google.com\/patent\/WO2023209729A1 (2023)."},{"key":"32999_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0021-9673(01)94598-4","volume":"386","author":"D Guo","year":"1987","unstructured":"Guo, D., Mant, C. T. & Hodges, R. S. Effects of ion-pairing reagents on the prediction of peptide retention in reversed-phase high-resolution liquid chromatography. J. Chromatogr. A. 386, 205\u2013222. https:\/\/doi.org\/10.1016\/S0021-9673(01)94598-4 (1987).","journal-title":"J. Chromatogr. A"},{"key":"32999_CR34","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1021\/ac50022a048","volume":"49","author":"C Horvath","year":"1977","unstructured":"Horvath, C., Melander, W., Molnar, I. & Molnar, P. Enhancement of retention by Ion-Pair formation in liquid chromatography with nonpolar stationary phases. Anal. Chem. 49, 2295\u20132305. https:\/\/doi.org\/10.1021\/ac50022a048 (1977).","journal-title":"Anal. Chem."},{"key":"32999_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.chroma.2004.08.052","volume":"1052","author":"D Guillarme","year":"2004","unstructured":"Guillarme, D., Heinisch, S. & Rocca, J. L. Effect of temperature in reversed phase liquid chromatography. J. Chromatogr. A. 1052, 39\u201351. https:\/\/doi.org\/10.1016\/j.chroma.2004.08.052 (2004).","journal-title":"J. Chromatogr. A"},{"key":"32999_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9673(00)94245-6","volume":"464","author":"G Szepesi","year":"1991","unstructured":"Szepesi, G., Gazdag, M. & Mih\u00e1lyfi, K. Selection of high-performance liquid chromatographic methods in pharmaceutical analysis. III. Method validation. J. Chromatogr. A. 464, 265\u2013278. https:\/\/doi.org\/10.1016\/S0021-9673(00)94245-6 (1991).","journal-title":"J. Chromatogr. A"},{"key":"32999_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/analytica6030025","volume":"6","author":"FR Mansour","year":"2025","unstructured":"Mansour, F. R., Locatelli, M. & Bedair, A. Stability toolkit for the appraisal of Bio\/Pharmaceuticals\u2019 level of endurance (STABLE) as a framework and software to evaluate the stability of pharmaceuticals. Analytica 6, 25. https:\/\/doi.org\/10.3390\/analytica6030025 (2025).","journal-title":"Analytica"},{"key":"32999_CR38","first-page":"1","volume":"2","author":"ICH Harmon","year":"2022","unstructured":"ICH Q2(R2) & Harmon, I. C. H. Validation of analytical procedures. Tripart Guidel. 2, 1\u201334 (2022).","journal-title":"Tripart Guidel"},{"key":"32999_CR39","doi-asserted-by":"publisher","first-page":"120802","DOI":"10.1016\/j.saa.2021.120802","volume":"270","author":"SF El-Malla","year":"2022","unstructured":"El-Malla, S. F., Elattar, R. H., Kamal, A. H. & Mansour, F. R. A highly sensitive switch-on spectrofluorometric method for determination of ascorbic acid using a selective eco-friendly approach. Spectrochim Acta Part. Mol. Biomol. Spectrosc. 270, 120802. https:\/\/doi.org\/10.1016\/j.saa.2021.120802 (2022).","journal-title":"Spectrochim Acta Part. Mol. Biomol. Spectrosc."},{"key":"32999_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/separations9100275","volume":"9","author":"EY Santali","year":"2022","unstructured":"Santali, E. Y. et al. Greenness assessment of chromatographic methods used for analysis of empagliflozin: a comparative study. Separations 9, 275 (2022).","journal-title":"Separations"},{"key":"32999_CR41","doi-asserted-by":"publisher","first-page":"100112","DOI":"10.1016\/j.greeac.2024.100112","volume":"9","author":"K Suthar","year":"2024","unstructured":"Suthar, K. & Desai, S. A comparative greenness assessment of chromatographic methods for cilnidipine analysis and its combination. Green. Anal. Chem. 9, 100112 (2024).","journal-title":"Green. Anal. Chem."},{"key":"32999_CR42","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira, F., Wojnowski, W. & Tobiszewski, M. AGREE\u2014Analytical greenness metric approach and software. Anal. Chem. 92, 10076\u201310082. https:\/\/doi.org\/10.1021\/acs.analchem.0c01887 (2020).","journal-title":"Anal. Chem."},{"key":"32999_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/analytica5030030","volume":"5","author":"F.R Mansour","year":"2024","unstructured":"MansourF.R., P\u0142otka-Wasylka, J. & Locatelli, M. Modified GAPI (MoGAPI) tool and software for the assessment of method greenness: case studies and applications. Analytica 5, 451\u2013457. https:\/\/doi.org\/10.3390\/analytica5030030 (2024).","journal-title":"Analytica"},{"key":"32999_CR44","doi-asserted-by":"publisher","first-page":"100126","DOI":"10.1016\/j.greeac.2024.100126","volume":"10","author":"FR Mansour","year":"2024","unstructured":"Mansour, F. R., Omer, K. M. & P\u0142otka-Wasylka, J. A total scoring system and software for complex modified GAPI (ComplexMoGAPI) application in the assessment of method greenness. Green. Anal. Chem. 10, 100126. https:\/\/doi.org\/10.1016\/j.greeac.2024.100126 (2024).","journal-title":"Green. Anal. Chem."},{"key":"32999_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13065-025-01486-2","volume":"19","author":"FR Mansour","year":"2025","unstructured":"Mansour, F. R. & Nowak, P. M. Introducing the carbon footprint reduction index (CaFRI) as a software-supported tool for greener laboratories in chemical analysis. BMC Chem. 19, 121. https:\/\/doi.org\/10.1186\/s13065-025-01486-2 (2025).","journal-title":"BMC Chem."},{"key":"32999_CR46","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1039\/D3GC02347H","volume":"25","author":"N Manousi","year":"2023","unstructured":"Manousi, N., Wojnowski, W., P\u0142otka-Wasylka, J. & Samanidou, V. Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality. Green. Chem. 25, 7598\u20137604. https:\/\/doi.org\/10.1039\/D3GC02347H (2023).","journal-title":"Green. Chem."},{"key":"32999_CR47","doi-asserted-by":"publisher","first-page":"100164","DOI":"10.1016\/j.sampre.2025.100164","volume":"14","author":"FR Mansour","year":"2025","unstructured":"Mansour, F. R., Bedair, A. & Locatelli, M. Click analytical chemistry index as a novel concept and framework, supported with open source software to assess analytical methods. Adv. Sample Prep. 14, 100164. https:\/\/doi.org\/10.1016\/j.sampre.2025.100164 (2025).","journal-title":"Adv. Sample Prep"},{"key":"32999_CR48","doi-asserted-by":"crossref","unstructured":"Fouqueray, P., Chevalier, C. & Bolze, S. Pharmacokinetics of Imeglimin in Caucasian and Japanese healthy Subjects, Clin. Drug Investig. 721\u2013732. (2022).","DOI":"10.1007\/s40261-022-01181-3"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32999-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32999-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32999-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:13:53Z","timestamp":1768342433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32999-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32999"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32999-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1334"}}